Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150,456 | 180,991 | 465,867 | 132,984 | 119,456 |
| Marketable Securities | 265,198 | 264,957 | N/A | N/A | N/A |
| Receivables | 4,846 | 3,147 | 1,214 | 531 | 3,153 |
| TOTAL | $424,504 | $452,589 | $469,596 | $136,961 | $125,221 |
| Non-Current Assets | |||||
| PPE Net | 3,986 | 2,454 | 2,122 | 1,376 | 1,053 |
| Investments And Advances | 15,391 | 2,464 | 0 | 0 | 0 |
| Intangibles | 37,869 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 75 | 347 | 833 | 428 | 188 |
| TOTAL | $57,321 | $5,265 | $2,955 | $1,804 | $1,241 |
| Total Assets | $481,825 | $457,854 | $472,551 | $138,765 | $126,462 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,086 | 4,413 | 3,961 | 3,680 | 5,030 |
| Accrued Expenses | 10,934 | 8,955 | 10,148 | 10,097 | 5,758 |
| TOTAL | $31,066 | $33,100 | $31,863 | $40,724 | $44,215 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 15,046 | 19,732 | 17,754 | 26,947 | 33,427 |
| Other Non-Current Liabilities | 3,750 | 0 | 0 | 10,331 | 989 |
| TOTAL | $189,137 | $181,537 | $200,000 | $10,331 | $3,581 |
| Total Liabilities | $220,203 | $214,637 | $231,863 | $51,055 | $47,796 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,904 | 12,645 | 12,455 | 12,447 | N/A |
| Common Shares | 6 | 6 | 6 | N/A | N/A |
| Retained earnings | -100,852 | -103,952 | -104,519 | -78,259 | -61,643 |
| Other shareholders' equity | -339 | 75 | 0 | 164,964 | 139,963 |
| TOTAL | $261,622 | $243,217 | $240,688 | $87,710 | $78,666 |
| Total Liabilities And Equity | $481,825 | $457,854 | $472,551 | $138,765 | $126,462 |